Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: a double-blind, randomized, placebo-controlled trial.

Raobaikady R, Redman J, Ball JA, Maloney G, Grounds RM
Br J Anaesth 2005;94(5):586-591.
NATA Rating :
Review by : M. Aldouri
NATA Review

This randomized study did not show significant difference between perioperative blood loss or blood transfusion requirement by prophylactic
use of rFVIIa in patients with normal hemostasis undergoing pelvic surgery. No adverse events were reported in either group.

– Maadh Aldouri

Consent Management Platform by Real Cookie Banner